Using cfMethylPre, we identified and validated three novel genes—PCDHA10, PRICKLE2, and PRTG—that exhibit inhibitory effects on breast cancer cell proliferation and migration, highlighting its potential in precision oncology. Here, PRTG is linked to breast carcinoma.